People with Cancer More Likely to Declare Bankruptcy

This article originally appeared here.
Share this content:
Cancer Diagnosis Tied to Increased Bankruptcy Risk
Cancer Diagnosis Tied to Increased Bankruptcy Risk

(HealthDay News) -- People with cancer are more than two and a half times as likely to declare bankruptcy as similarly aged people without cancer, according to a study published online May 15 in Health Affairs.

Scott Ramsey, M.D., Ph.D., from the Fred Hutchinson Cancer Research Center in Seattle, and colleagues estimated the incidence and relative risk of bankruptcy for people age 21 or older diagnosed with cancer compared to people the same age without cancer. Retrospective cohort analysis utilized a variety of medical, personal, legal, and bankruptcy sources covering the Western District of Washington State in U.S. Bankruptcy Court (1995 to 2009).

The researchers found that cancer patients were 2.65 times more likely to go bankrupt than people without cancer. Bankruptcy rates were two to five times higher among younger cancer patients compared to cancer patients age 65 years or older, which indicates that Medicare and Social Security may mitigate bankruptcy risk for the older group.

"The findings suggest that employers and governments may have a policy role to play in creating programs and incentives that could help people cover expenses in the first year following a cancer diagnosis," the authors write.

Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs